The present invention is based, in part, on the discovery of monoclonalantibodies, and antigen-binding fragmentsthereof, that specifically bind to HHLA2, as well as immunoglobulins,polypeptides, nucleic acids thereof, and methods of using suchantibodies for diagnostic, prognostic, and therapeutic purposes.